Targeted detection of mutations associated with imatinib-resistance. Strategies to increase sensitivity and specificity

Susan Branford, Timothy Hughes, Detection of BCR-ABL mutations and resistance to imatinib mesylate. Methods in molecular medicine. ,vol. 125, pp. 93- 106 ,(2006) , 10.1385/1-59745-017-0:93

Michael W.N. Deininger, John M. Goldman, Nicholas Lydon, Junia V. Melo, The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells Blood. ,vol. 90, pp. 3691- 3698 ,(1997) , 10.1182/BLOOD.V90.9.3691

P. C. Nowell, A minute chromosome in human chronic granulocytic leukemia Science. ,vol. 132, pp. 1497- ,(1960)

Dick R. Gourley, Eric T. Herfindal, Textbook of Therapeutics: Drug and Disease Management ,(1996)

G Martinelli, S Soverini, G Rosti, M Baccarani, Dual tyrosine kinase inhibitors in chronic myeloid leukemia. Leukemia. ,vol. 19, pp. 1872- 1879 ,(2005) , 10.1038/SJ.LEU.2403950

J S Khorashad, M Anand, D Marin, S Saunders, T Al-Jabary, A Iqbal, S Margerison, J V Melo, J M Goldman, J F Apperley, J Kaeda, The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib. Leukemia. ,vol. 20, pp. 658- 663 ,(2006) , 10.1038/SJ.LEU.2404137

Mercedes E Gorre, Mansoor Mohammed, Katharine Ellwood, Nicholas Hsu, Ron Paquette, P Nagesh Rao, Charles L Sawyers, Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification Science. ,vol. 293, pp. 876- 880 ,(2001) , 10.1126/SCIENCE.1062538

F X E Gruber, T Lamark, A Ånonli, M A Sovershaev, M Olsen, T Gedde-Dahl, H Hjort-Hansen, B Skogen, Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL Leukemia. ,vol. 19, pp. 2159- 2165 ,(2005) , 10.1038/SJ.LEU.2403983

Nathalie Sorel, Florence Chazelas, André Brizard, Jean-Claude Chomel, Double-Gradient–Denaturing-Gradient Gel Electrophoresis for Mutation Screening of the BCR-ABL Tyrosine Kinase Domain in Chronic Myeloid Leukemia Patients Clinical Chemistry. ,vol. 51, pp. 1263- 1266 ,(2005) , 10.1373/CLINCHEM.2004.047274

Neil P. Shah, John M. Nicoll, Bhushan Nagar, Mercedes E. Gorre, Ronald L. Paquette, John Kuriyan, Charles L. Sawyers, Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia Cancer Cell. ,vol. 2, pp. 117- 125 ,(2002) , 10.1016/S1535-6108(02)00096-X